# Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

> **NCT05901779** · NA · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 318 (estimated)

## Conditions studied

- Gastric Cancer
- Neoadjuvant Chemotherapy

## Interventions

- **DRUG:** live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules

## Key facts

- **NCT ID:** NCT05901779
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 318 (ESTIMATED)
- **Last updated:** 2023-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05901779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05901779, "Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05901779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*